Medigus
Omez
About Medigus
Medical device company focused on innovative endoscopic procedures and devices. Medigus developed an entire endoscopic system for intraluminal treatment of GERD (Gastroesophageal Reflux Disease), one of the most common chronic diseases in the Western world. The endoscopic system for the treatment of GERD - the SRS - combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment in a single instrument. The SRS system and its unique flexible endoscope allows gastroenterologists and surgeons to perform endoluminally a true partial anterior fundoplication, thereby revolutionizing the treatment of GERD by eliminating the need for open or laparoscopic surgery - the current standard practice for treating severe GERD. Shifting the GERD treatment from surgery to an endoluminal procedure, without opening the abdominal cavity, is a REVOLUTION. In addition, Medigus designs and manufactures endoscopy systems for partner companies based on its proprietary technologies, which include all necessary elements for performing a wide range of endoscopic procedures such as the world’s smallest video cameras, respective video processors and endoscopy suits, and various types of rigid, semi-flexible and flexible disposable video endoscopes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $30.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2015)
- Ticker: tlv:MDGS
- Website: medigus.com
- Phone: +972 864-6688
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/medigus-192631 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.